Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a)

M. Kosar, J. Bartkova, S. Hubackova, Z. Hodny, J. Lukas, J. Bartek,

. 2011 ; 10 (3) : 457-68. [pub] 20110201

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 2002 to 1 year ago
PubMed Central from 2009 to 1 year ago
Europe PubMed Central from 2009 to 1 year ago

Cellular senescence, an irreversible proliferation arrest evoked by stresses such as oncogene activation, telomere dysfunction, or diverse genotoxic insults, has been implicated in tumor suppression and aging. Primary human fibroblasts undergoing oncogene-induced or replicative senescence are known to form senescence-associated heterochromatin foci (SAHF), nuclear DNA domains stained densely by DAPI and enriched for histone modifications including lysine9-trimethylated histone H3. While cellular senescence occurs also in premalignant human lesions, it is unclear how universal is SAHF formation among various cell types, under diverse stresses, and whether SAHF occur in vivo. Here, we report that human primary fibroblasts (BJ and MRC-5) and primary keratinocytes undergoing replicative senescence, or premature senescence induced by oncogenic H-Ras, diverse chemotherapeutics and bacterial cytolethal distending toxin, show differential capacity to form SAHF. Whereas all tested cell types formed SAHF in response to activated H-Ras, only MRC-5, but not BJ fibroblasts or keratinocytes, formed SAHF under senescence induced by etoposide, doxorubicin, hydroxyurea, bacterial intoxication or telomere attrition. In addition, DAPI-defined SAHF were detected on paraffin sections of Ras-transformed cultured fibroblasts, but not human lesions at various stages of tumorigenesis. Overall, our results indicate that unlike the widely present DNA damage response marker γH2AX, SAHF is not a common feature of cellular senescence. Whereas SAHF formation is shared by diverse cultured cell types under oncogenic stress, SAHF are cell-type-restricted under genotoxin-induced and replicative senescence. Furthermore, while the DNA/DAPI-defined SAHF formation in cultured cells parallels enhanced expression of p16(ink4a) , such 'prototypic' SAHF are not observed in tissues, including premalignant lesions, irrespective of enhanced p16(ink4a) and other features of cellular senescence.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027866
003      
CZ-PrNML
005      
20250506135439.0
007      
ta
008      
120817s2011 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.4161/cc.10.3.14707 $2 doi
035    __
$a (PubMed)21248468
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kosar, Martin $u Department of Genome Integrity, Institute of Molecular Genetics v.v.i, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
245    10
$a Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a) / $c M. Kosar, J. Bartkova, S. Hubackova, Z. Hodny, J. Lukas, J. Bartek,
520    9_
$a Cellular senescence, an irreversible proliferation arrest evoked by stresses such as oncogene activation, telomere dysfunction, or diverse genotoxic insults, has been implicated in tumor suppression and aging. Primary human fibroblasts undergoing oncogene-induced or replicative senescence are known to form senescence-associated heterochromatin foci (SAHF), nuclear DNA domains stained densely by DAPI and enriched for histone modifications including lysine9-trimethylated histone H3. While cellular senescence occurs also in premalignant human lesions, it is unclear how universal is SAHF formation among various cell types, under diverse stresses, and whether SAHF occur in vivo. Here, we report that human primary fibroblasts (BJ and MRC-5) and primary keratinocytes undergoing replicative senescence, or premature senescence induced by oncogenic H-Ras, diverse chemotherapeutics and bacterial cytolethal distending toxin, show differential capacity to form SAHF. Whereas all tested cell types formed SAHF in response to activated H-Ras, only MRC-5, but not BJ fibroblasts or keratinocytes, formed SAHF under senescence induced by etoposide, doxorubicin, hydroxyurea, bacterial intoxication or telomere attrition. In addition, DAPI-defined SAHF were detected on paraffin sections of Ras-transformed cultured fibroblasts, but not human lesions at various stages of tumorigenesis. Overall, our results indicate that unlike the widely present DNA damage response marker γH2AX, SAHF is not a common feature of cellular senescence. Whereas SAHF formation is shared by diverse cultured cell types under oncogenic stress, SAHF are cell-type-restricted under genotoxin-induced and replicative senescence. Furthermore, while the DNA/DAPI-defined SAHF formation in cultured cells parallels enhanced expression of p16(ink4a) , such 'prototypic' SAHF are not observed in tissues, including premalignant lesions, irrespective of enhanced p16(ink4a) and other features of cellular senescence.
650    _2
$a bakteriální toxiny $x farmakologie $7 D001427
650    _2
$a stárnutí buněk $x účinky léků $x genetika $x fyziologie $7 D016922
650    _2
$a buněčné linie $7 D002460
650    _2
$a proliferace buněk $7 D049109
650    _2
$a inhibitor p16 cyklin-dependentní kinasy $x genetika $x metabolismus $x fyziologie $7 D019941
650    _2
$a poškození DNA $7 D004249
650    _2
$a geny ras $7 D011905
650    _2
$a heterochromatin $x chemie $7 D006570
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bartkova, Jirina
700    1_
$a Hubackova, Sona
700    1_
$a Hodny, Zdenek
700    1_
$a Lukas, Jiri
700    1_
$a Bártek, Jiří, $d 1953- $7 xx0046271
773    0_
$w MED00173232 $t Cell Cycle $x 1551-4005 $g Roč. 10, č. 3 (2011), s. 457-68
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21248468 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20250506135438 $b ABA008
999    __
$a ok $b bmc $g 949908 $s 785212
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 10 $c 3 $d 457-68 $e 20110201 $i 1551-4005 $m Cell Cycle $n Cell Cycle $x MED00173232
LZP    __
$a Pubmed-20120817/11/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...